Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...

In the year after surgery for primary congenital glaucoma, gas-permeable contact lenses led to significantly better visual ...

UnitedHealth Group (UHG) is artificially inflating risk adjustment scores of patients in its Medicare Advantage plans in ...

Holding announced that its neuroprotective candidate Privosegtor was granted breakthrough therapy designation by the U.S. Food and ...

Acuity stock is near highs and headlines the latest earnings calendar along with data center operator Applied Digital.

Background/Aims On 17 September 2024, over 3000 pager devices containing explosives were remotely detonated across Lebanon in ...

Last year, it emerged that Health New Zealand used an Excel spreadsheet as its "primary data file" for managing and analysing ...

Accuity, an AI-driven clinical intelligence and revenue integrity partner for leading health systems, today announced its 2025 results, reporting more than $800 million in cash benefits delivered to ...

U.S. Energy Secretary Chris Wright also noted yesterday that the revenue from sales of Venezuelan oil would be used to ...